National Award project Lianhuaqingwen plays an important role in epidemic prevention and control

A novel coronavirus pneumonia diagnosis and treatment plan (trial version sixth) was released jointly by the National Health Protection Committee and the State Administration of traditional Chinese medicine It recommended that Lianhua Qingwen capsules and granules be used for medical observation All novel coronavirus pneumonia and prevention and control schemes were recommended by more than 20 provinces and municipalities in Wuhan, Guangzhou, Zhejiang and Shandong Novel coronavirus pneumonia has been applied to novel coronavirus pneumonia since 2005, and has been recommended for more than 20 times at the national level for the prevention and control of major public health events such as influenza, avian influenza and new coronavirus pneumonia The reason why Lianhua Qingwen capsule has been recommended repeatedly is that the scientific research achievements of Lianhua Qingwen capsule won the second prize of 2011 National Science and technology progress, which is an advantage that other similar drugs do not have In fact, in every major viral public health event in China, Lianhua Qingwen's scientific and technological innovation always plays an important role Lianhua Qingwen is to explore the law and treatment of exogenous febrile disease and the spread and change of pestilence by using the theory of collateral disease of traditional Chinese medicine, and to put forward the treatment countermeasures of "active intervention": to treat both exterior and interior diseases with the same method of protecting Qi; to treat the disease with the first syndrome, to cut off the disease; to regulate the whole, to treat with multiple targets, and to formulate the treatment method of "clearing the plague, detoxifying, and releasing the lung and heat" The prescription absorbed the essence of medicine used for treating exogenous febrile diseases and epidemic syndromes in the past dynasties In the treatise on febrile diseases, the mixture of Ma Xing Shi Gan Tang and "febrile diseases" was used to extract yinqiao powder, and Wu Youke's "epidemic febrile disease" theory was used to treat the disease Lianhua Qingwen uses rhubarb to dredge the internal organs and release the lung The lung and large intestine are outward and inward, so that the "epidemic virus" can be discharged from the stool, so that there is a way out for the evil; another value of using rhubarb is to use drugs in advance to cut off the disease Wu Youke of Ming Dynasty once pointed out that the treatment of plague should attack and expel the evil Qi as soon as possible when the healthy qi of human body is not declining, and the application of Rhubarb for defecation in advance can cut off the transmission of disease to the critical state This novel coronavirus pneumonia has some stools and thin stools, which is a kind of foul and turbid pathogenic disease that does not interfere with the application of rhubarb to go out of the evil spirits This is the common law of TCM Modern pharmacodynamic study confirmed that rhubarb has the effect of inhibiting lung inflammation and improving lung function The application of Agastache fragrances to wet, avoid pollution and turbidity The novel coronavirus pneumonia has a prominent feature, which is the heavy damp and Turbid Toxin Especially in the Hubei epidemic area, it is humid and cold The patients show poor appetite and loose stools The patchouli is able to avoid the pollution and turbid, and improve the condition of poor appetite and dampness and spleen and stomach A novel coronavirus pneumonia is the key to the treatment of Lianhua Qingwen It is grown in cold and high altitude areas, and has the function of reinforcing lung, relieving asthma and activating blood circulation It can improve the body's ability of resisting fatigue and hypoxia, and it can cope with the multiple organ damage caused by the weakness, shortness of breath and low oxygen content of the patients with new crown pneumonia At the same time, the immune enhancing effect of Rhodiola can improve the disease resistance of patients caused by low lymphocyte and subpopulation, and improve the disease resistance and rehabilitation ability Novel coronavirus and novel coronavirus (COVID-19) infection were caused by Lianhua Qingwen, a professor of academician Zhong Nanshan, who was professor of the National Key Laboratory of respiratory diseases, Guangzhou Medical University, and launched a cell model study in February 18th at the Guangdong provincial government's Conference on epidemic prevention and control Professor Yang Zifeng, the National Key Laboratory of respiratory diseases, Medical University of Beijing, pointed out that Lianhua Qingwen is a common disease causing common coronavirus (HCoV-229E) and new coronavirus (PCR) infection Cytopathy has a good inhibitory effect In addition, Lianhuaqingwen can inhibit the expression of TNF - α, IL-6, CCL2 / MCP-1 and cxcl-10 / IP-10 inflammatory factors induced by hcov-229e and covid-19 infected cells The novel coronavirus displayed a novel coronavirus at the cell level, showing the anti viral and anti-inflammatory effects, and it brought hope for the treatment of new coronavirus infection Novel coronavirus, SARS, influenza A, H1N1, H3N2, avian flu H5N1, H9N2 and other viruses are obviously inhibited by China's Institute of respiratory diseases, Military Medical Science Academy of the PLA, China Academy of Chinese medicine and other scientific research institutes, which can effectively control many kinds of bacteria, which is beneficial to treat mixed infections It can regulate immunity, enhance the ability of disease resistance and rehabilitation, reduce the repeated attack of influenza and pulmonary infection, showing the characteristic advantage of overall regulation Clinical study confirmed that the treatment effect of influenza and acute upper respiratory tract infection is accurate Multi center, randomized double-blind, positive drug control 440 cases clinical study showed that Lianhua Qingwen capsule is significantly better than the control group in the treatment of influenza syndrome apparent efficiency, body temperature apparent efficiency, fever, pharyngeal pain, cough, muscle ache and other symptoms The clinical observation of 206 patients with acute viral upper respiratory tract infection showed that the total effective rate, the total score of disease severity and the improvement of symptoms such as fever, chills, limb soreness and headache were significantly better than those of the control group Evidence based medicine research shows that the treatment of influenza A (H1N1) is effective A multicenter, randomized, double-blind, controlled treatment of 256 cases of H1N1 with oseltamivir phosphate, a western medicine, led by Beijing You'an Hospital Affiliated to Capital Medical University, confirmed that there was no difference in the time of nucleic acid turning negative and the time of all influenza symptoms relieving between Lianhua Qingwen virus and oseltamivir phosphate, reducing the severity of the disease, reducing fever and relieving cough, headache, fatigue, muscle ache, etc Symptoms are better than oseltamivir phosphate, no adverse reactions, showing the advantages of traditional Chinese medicine treatment The clinical evidence-based medicine research undertaken by Academician Wang Chen and participated by 13 top three hospitals in China, such as Beijing Hospital of the Ministry of health, Chaoyang Hospital of Capital Medical University, Xuanwu Hospital of Capital Medical University and Guangdong Hospital of traditional Chinese medicine, shows that Lianhua Qingwen has a good effect in improving the clinical symptoms of viral pneumonia patients, such as fever, cough and cough, expectoration, chest pain, muscle ache and dyspnea Since the industrialization of the research achievements of Lianhuaqingwen, Lianhuaqingwen has played an important role in the viral public health events in China As an enterprise with a high sense of social responsibility, Yiling pharmaceutical always takes the lead in donating drugs to the epidemic area in every epidemic situation In recent years, the donation value of Lianhua Qingwen reached more than 100 million In 2009, there was a mass epidemic of H1N1 in some areas of China Only in the peak period of three months, the application of Lianhuaqingwen reached more than 20 million people At the same time, the prevention of Lianhuaqingwen in the epidemic area has achieved good results On September 4, 2009, the Health Bureau of Langfang City, Hebei Province reported the occurrence of clustered influenza A (H1N1) cases in the university town of the development zone of the city The prevention and control expert group quickly isolated more than 20000 people who had close contact with the confirmed patients and the surrounding healthy people Among the isolated population, 6367 chose to take Lianhuaqingwen for prevention, 1177 chose other drugs for prevention, and 13009 did not take drugs for prevention The results showed that the infection rate was 8.8% in the control group, 6.8% in the control group, and only 1.2% in the control group Novel coronavirus pneumonia has been recommended in all the major public health events in China since the influenza A, B, avian flu and new coronavirus pneumonia It has been recommended for treatment in all the major viral public health emergencies in China It has been included in the guidelines for influenza diagnosis and treatment, the diagnosis and treatment plan of human influenza a H1N1 influenza, the Chinese medicine prevention and treatment plan for influenza B, and H7N9 avian influenza infection The novel coronavirus infection diagnosis and treatment plan (2019 Edition), the new pneumonia diagnosis and treatment plan for coronavirus infection (trial version sixth), and so on, has been repeatedly epidemic prevention and control Facing the emerging novel coronavirus pneumonia, Yiling pharmaceutical donated about ten million yuan to the epidemic area through the Red Cross Society of China for the first time It also made it clear that the Yiling pharmaceutical care for the people in the affected area was to make the early treatment and early treatment of the epidemic area Subsequently, nine million boxes of drugs were guaranteed in the epidemic area of Hubei Province, roughly estimated to cover millions of people in Hubei Province All the shelter hospitals in Wuhan also used Lianhua Qingwen as the basic drug Up to now, about 30 million people have applied Lianhua Qingwen in China Hubei Province, Heilongjiang Province and many other provinces and cities will use Lianhua Qingwen capsule / granule as reserve medicine, and the Ministry of industry and information technology will use it as the medical emergency support materials in the list of key materials for epidemic prevention and control On February 18th, novel coronavirus pneumonia was put forward at the conference held at the Guangdong provincial government's Conference on prevention and control of epidemic diseases Zhong Nanshan, a Chinese medicine herb, has been used in the clinical treatment of new crown pneumonia It shows that the use of Chinese medicine can reduce the virus entry into cells and reduce the symptoms of inflammation This can provide some evidence for the use of Chinese medicine Professor Zhang Boli, an expert in traditional Chinese medicine of the central steering group, academician of the Chinese Academy of engineering and President of Tianjin University of traditional Chinese medicine, said in an interview with the relevant media, "from now on, there are more drugs that can inhibit and kill the coronavirus itself, and those that have positive effects after the experiment are written in the instructions are Lianhua Qingwen." First, second novel coronavirus infected patients with pneumonia in Shaanxi were cured and discharged Experts said that two patients were treated with Lianhua Qingwen capsules and granules and treated with integrated traditional Chinese and Western medicine Liu Qingguang, vice president of the First Affiliated Hospital of Xi'an Jiaotong University, said in an interview that the hospital treated the patients in strict accordance with the relevant national standards, combined with the patients' conditions, and adopted some methods of traditional Chinese medicine, such as Lianhua Qingwen granules, which had a good effect and a very smooth recovery In February 7th, 11 novel coronavirus pneumonia patients in Huanggang, Hubei were cured and discharged Liu Yi, captain of the Hunan team supporting the Hubei medical team, said: "our treatment is mainly antiviral treatment, Chinese medicine Lianhua Qingwen capsule, and Western medicine LPN", and symptomatic support In the large-scale use of Lianhuaqingwen in the epidemic area, both confirmed patients and suspected cases also showed good results The clinical reports of Lianhua Qingwen granule treatment were published in the world traditional Chinese medicine, the Journal of traditional Chinese medicine and the Chinese Journal of experimental prescriptions respectively by the General Hospital of Wuhan University of science and technology, the Ninth Hospital of Wuhan city and the Wuhan General Hospital of China Resources steel Novel coronavirus pneumonia was treated by novel coronavirus pneumonia combined with routine treatment of 54 cases of PNS in Pu Ren Hospital Affiliated to Wuhan University of Science and Technology Results showed that Lianhua Qingwen granule significantly improved fever, cough and fatigue in patients with new coronavirus pneumonia, and reduced fever, fatigue and cough duration 42 patients with novel coronavirus pneumonia were diagnosed in the Ninth Hospital of Wuhan and Huarun General Hospital of Wuhan Iron and steel group The results showed that: Lianhua Qingwen treatment group can significantly alleviate the clinical symptoms of fever, cough, expectoration, shortness of breath, especially in improving the fever symptoms, showing a unique advantage The disappearance time of fever was 1.5 days shorter than that of the control group on average, and it can also improve fatigue, muscle pain and other symptoms 101 cases of suspected novel coronavirus pneumonia were treated in the Huarun General Hospital of WISCO, Wuhan University of Science and Technology 63 cases were treated with Lianhua Qingwen treatment group and 38 cases in the control group The results showed that Lianhua Qingwen could significantly improve the symptoms of fever, cough and fatigue, and shorten the fever time for 1 days.